Home Our Company Resource Library
  • Oncology and Hematology
  • Oncology
  • Non-Malignant Hematology

Targeted Therapies for Solid Tumors

02.21.20
  • Oncology and Hematology

End-to-End Expertise and Regulatory Knowledge in Early Phase Oncology

02.21.20

Trends in the Design and Conduct of Pharmacokinetic Studies in Patients with Impaired Hepatic Function

11.21.19

Trends in the Design and Conduct of Pharmacokinetic Studies in Patients with Impaired Renal Function

11.21.19
  • Oncology and Hematology
  • Clinical Trials

Underreporting of Patient Reported Outcomes (PRO) in Myeloproliferative Neoplasms (MPNs) Clinical Trials

11.15.19
  • Bioanalytical Solutions

Cannabis Center of Excellence

09.12.19
  • Translational Science

Translational Science

07.09.19
  • Value and Access
  • Commercialization

Syneos Health Value and Access

04.26.19
  • Early Phase
  • Critical Reagents

The Importance of Characterizing your Critical Reagents - Trastuzumab as a Case Study

02.18.19
  • Rare Disease

Rare Disease Consortium Brochure

11.01.18
  • Immunology and Inflammation

Best-in-Class Immunology and Inflammation Clinical Research

06.28.18
  • Safety and Pharmacovigilance

Focusing on Quality in Global Pharmacovigilance Services

06.28.18